Market Research Logo

Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020

Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020

Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It is an autoimmune disease and may be triggered by smoking, alcohol consumption, cold or dry weather and stress.

In the wake of lesser treatment options and costly therapies, psoriasis remains as an under treated disease. Psoriasis treatment can be divided into three main groups: topical treatment, light therapy, and systemic medication based on the severity of the disease. The typical treatment options include TNF inhibitors and IL inhibitors. However, various therapies and drugs are in the pipeline and it is expected that treatment options will improve over time with higher efficacy and lower costs.

The global market for psoriasis has been increasing consistently over the last few years. The major factors contributing to the growth of the global psoriasis market are increasing smoking and alcohol consumption trends globally. Surging smoking population, increased spending on medicines, increasing sales of prescription drugs and escalating health care expenditure are the key growth drivers of the market. However, growth of the market is hindered by extensive drug development and approval process and side-effects associated with the existing medication for psoriasis.

Various treatment methods are readily used to control psoriasis in the US, such as TNFs, systemics and topicals. With relatively higher prevalence rates in the US, several companies are trying to grab larger market shares with their new and innovative drugs. Plaque psoriasis is a common form of this disease in the US with increasing prevalence each year.

The report “Global Psoriasis Market” analyzes the development of this market, with focus on the US treatment market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Johnson and Johnson, Abbvie inc., Amgen Inc. and Novartis are being profiled along with their key financials and strategies for growth.

1. Market Overview
1.1 Psoriasis
1.2 Types
1.2.1 Plaque Psoriasis
1.2.2 Guttate Psoriasis
1.2.3 Inverse Psoriasis
1.2.4 Pustular Psoriasis
1.2.5 Erytherodermic Psoriasis
1.3 Causes
1.4 Symptoms by Types
1.4.1 Plaque Psoriasis
1.4.2 Guttate Psoriasis
1.4.3 Inverse Psoriasis
1.4.4 Pustular Psoriasis
1.4.5 Erytherodermic Psoriasis
1.5 Diagnosis
1.6 Treatment Options
Table 1: Current Treatment Options for Psoriasis
1.6.1 Topical Treatments
1.6.2 Light Therapy or Phototherapy
1.6.3 Systemic Treatments
2. Global Market
2.1 Global Psoriasis Market by Value
Table 2: Global Psoriasis Market by Value (2013-2020E)
2.2 Global Psoriasis Market by Therapy
Table 3: Global Psoriasis Market by Therapy (2015)
Table 4: Global Psoriasis Market by Therapy (2025E)
3. The US Market
3.1 Autoimmune Disease Market
3.1.1 The US Autoimmune Disease Market by Value
Table 5: The US Autoimmune Disease Market by Value (2010-2015)
3.2 Psoriasis Market
3.2.1 The US Psoriasis Prevalence
Table 6: The US Psoriasis Prevalence (2016E-2020E)
3.2.2 The US Psoriasis Market by Value
Table 7: The US Psoriasis Market by Value (2010-2015)
Table 8: The US Psoriasis Market Forecast by Value (2016E-2020E)
3.2.3 The US Psoriasis Market by Treatment
Table 9: The US Psoriasis Market by Treatment (2015)
3.2.4 The US Psoriasis IL-Inhibitors Market by Value
Table 10: The US Psoriasis Market by IL Inhibitors (2016E-2020E)
3.3 Plaque Psoriasis Market
3.3.1 The US Plaque Psoriasis Prevalence
Table 11: The US Plaque Psoriasis Prevalence (2016E-2020E)
3.3.2 The US Plaque Psoriasis Patients on Treatment
Table 12: The US Plaque Psoriasis Patients On Treatment (2016E-2020E)
3.3.3 The US Plaque Psoriasis Biologics Market by Type
Table 13: The US Plaque Psoriasis Biologics Market by Type (2015)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Surging Smoking Population
Table 14: Global Cigarette Consumption (1910-2014)
4.1.2 Increased Spending on Medicines
Table 15: Global Spending on Medicines (2010-2020E)
4.1.3 Increasing Sales of Prescription Drugs
Table 16: Global Sales of Prescription Drugs (2010-2015E)
4.1.4 Escalating Healthcare Expenditure
Table 17: Global Per Capita Healthcare Expenditure (2006-2015E)
4.2 Key Trends
4.2.1 New Drugs against Psoriasis
Table A: Status of New Drugs against Psoriasis
4.2.2 Psoriasis Treatment Evolution
4.2.3 Key Pipeline Products in Conventional Therapies
Table B: Key Pipeline Products in Conventional Therapies (2015)
4.2.4 Development of IL Based Treatments
Table C: Key IL-Based Treatments in Development
4.2.5 Drug Development for Plaque Psoriasis
4.3 Challenges
4.3.1 Major Side-Effects of New Psoriasis Drugs
Table D: Major Side Effects of New Psoriasis Drugs
4.3.2 Extensive Drug Development and Approval Process
5. Competition
5.1 Global Market
5.1.1 Price Comparison of Key Biologic for Psoriasis
Table E: Price Comparison of Key Biologics (2015)
5.2 US Market
5.2.1 The US Psoriasis Biologics Revenue Comparison
Table F: Biologics Treatment by Revenue (2015)
5.2.2 The US Revenue Comparison per Patient for Psoriasis Drugs
Table 18: The US Annual Revenue Per Patient for Psoriasis Drugs (2015)
6. Company Profiles
6.1 Johnson & Johnson
6.1.1 Business Overview
Table 19: Johnson and Johnson’s Revenue Share by Segment (2015)
6.1.2 Financial Overview
Table 20: Johnson and Johnson’s Revenue and Net Income (2011-2015)
6.1.3 Business Strategies
Table G: J&J Research and Development Expenditure by Segments (2014-2015)
6.2 Abbvie Inc.
6.2.1 Business Overview
Table 21: Abbvie’s Revenue Share by Products (2015)
6.2.2 Financial Overview
Table 22: Abbvie Revenue and Net Income (2011-2015)
6.2.3 Business Strategies
Table 23: Abbvie’s Research & Development Expenditure (2013-2015)
6.3 Amgen Inc.
6.3.1 Business Overview
Table 24: Amgen’s Revenue Share by Products (2015)
6.3.2 Financial Overview
Table 25: Amgen Inc. Revenue and Net Income (2012-2015)
6.3.3 Business Strategies
Table 26: Amgen’s R&D Expenditure (2012-2015)
6.4 Novartis
6.4.1 Business Overview
Table 27: Novartis Revenue Share by Segments (2015)
6.4.2 Financial Overview
Table 28: Novartis Revenue and Net Income (2012-2015)
6.4.3 Business Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report